Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus.

Inclusion Criteria

• •Adult hemodialysis patients ≥18 years of age.
• •Signed informed consent to participate in the study.
• •Stable on hemodialysis prescription for ≥3 months.
• •Able to sustain hemodialysis 3x/week for 3 to 4 hours.
• •Hemoglobin concentration \>9.5 g/dL.
• •Serum TSAT ≥20%.
• •Receiving hemodialysis via AV fistula or graft.
• •Able to receive hemodialysis for 4 hours at each session over the duration of the treatment periods.
• •Able to receive intermittent heparin administration for anticoagulation of the dialysis circuit.
• •Serum TIBC ≥ 150 µg/dL.